Century Therapeutics (IPSC) Other Non Operating Income (2022 - 2025)
Historic Other Non Operating Income for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to $97000.0.
- Century Therapeutics' Other Non Operating Income fell 6120.0% to $97000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $278000.0, marking a year-over-year increase of 1880.34%. This contributed to the annual value of $354000.0 for FY2024, which is 19242.82% up from last year.
- According to the latest figures from Q3 2025, Century Therapeutics' Other Non Operating Income is $97000.0, which was down 6120.0% from $113000.0 recorded in Q2 2025.
- In the past 5 years, Century Therapeutics' Other Non Operating Income ranged from a high of $4.4 million in Q4 2022 and a low of -$194000.0 during Q1 2023
- In the last 4 years, Century Therapeutics' Other Non Operating Income had a median value of $11000.0 in 2024 and averaged $321133.3.
- Per our database at Business Quant, Century Therapeutics' Other Non Operating Income tumbled by 382000.0% in 2023 and then skyrocketed by 198333.33% in 2024.
- Quarter analysis of 4 years shows Century Therapeutics' Other Non Operating Income stood at $4.4 million in 2022, then tumbled by 100.34% to -$15000.0 in 2023, then surged by 806.67% to $106000.0 in 2024, then decreased by 8.49% to $97000.0 in 2025.
- Its Other Non Operating Income was $97000.0 in Q3 2025, compared to $113000.0 in Q2 2025 and -$38000.0 in Q1 2025.